Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
2008 Mar 27
Vandetanib trifluoroacetate A-767491 2008 Mar 27Vandetanib is an orally bioavailable 4 anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGF2), thereby blocking VEGF stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell
US$ 137.50
US$ 300.00
US$ 650.00
US$ 199.99
US$ 199.99
US$ 225.00
US$ 1099.99
US$ 1374.99
US$ 124.99
US$ 600.00